ES2580172T3 - Una célula madre mesenquimal multipotente aislada de glomérulos humanos adultos (HGL-MSC), un método para preparar la misma y usos de la misma en la medicina regenerativa del riñón - Google Patents

Una célula madre mesenquimal multipotente aislada de glomérulos humanos adultos (HGL-MSC), un método para preparar la misma y usos de la misma en la medicina regenerativa del riñón Download PDF

Info

Publication number
ES2580172T3
ES2580172T3 ES09744160.4T ES09744160T ES2580172T3 ES 2580172 T3 ES2580172 T3 ES 2580172T3 ES 09744160 T ES09744160 T ES 09744160T ES 2580172 T3 ES2580172 T3 ES 2580172T3
Authority
ES
Spain
Prior art keywords
mesenchymal stem
hgl
msc
stem cell
adult human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09744160.4T
Other languages
English (en)
Spanish (es)
Inventor
Giovanni Camussi
Stefania Bruno
Benedetta Bussolati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Medical Care Deutschland GmbH
Original Assignee
Fresenius Medical Care Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Deutschland GmbH filed Critical Fresenius Medical Care Deutschland GmbH
Application granted granted Critical
Publication of ES2580172T3 publication Critical patent/ES2580172T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0684Cells of the urinary tract or kidneys
    • C12N5/0687Renal stem cells; Renal progenitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662Stem cells
    • C12N5/0668Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES09744160.4T 2008-11-04 2009-11-02 Una célula madre mesenquimal multipotente aislada de glomérulos humanos adultos (HGL-MSC), un método para preparar la misma y usos de la misma en la medicina regenerativa del riñón Active ES2580172T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08425708 2008-11-04
EP08425708A EP2186883A1 (en) 2008-11-04 2008-11-04 An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
PCT/EP2009/064468 WO2010052192A1 (en) 2008-11-04 2009-11-02 An isolated multipotent mesenchymal stem cell from human adult glomeruli (hgl-msc), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney

Publications (1)

Publication Number Publication Date
ES2580172T3 true ES2580172T3 (es) 2016-08-19

Family

ID=40260686

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09744160.4T Active ES2580172T3 (es) 2008-11-04 2009-11-02 Una célula madre mesenquimal multipotente aislada de glomérulos humanos adultos (HGL-MSC), un método para preparar la misma y usos de la misma en la medicina regenerativa del riñón

Country Status (7)

Country Link
US (1) US9499796B2 (https=)
EP (2) EP2186883A1 (https=)
JP (1) JP5795737B2 (https=)
CN (1) CN102292434B (https=)
ES (1) ES2580172T3 (https=)
PL (1) PL2361303T3 (https=)
WO (1) WO2010052192A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2363136A1 (en) 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
TWI762890B (zh) 2010-05-12 2022-05-01 開曼群島商英瑞金公司 生物活性腎細胞
WO2012030968A1 (en) * 2010-08-31 2012-03-08 Renovocyte, LLC Systemic, allogenic stem cell therapies for treatment of diseases in animals
CN103261407B (zh) * 2010-12-22 2016-03-02 杜兰教育基金委员会 用于识别和培养具有高度增殖潜能的多能间充质干细胞的方法
AU2012279995C1 (en) 2011-07-06 2019-10-24 Cell Therapy Limited Progenitor cells of mesodermal lineage
EP2760995B1 (en) * 2011-09-30 2019-08-07 The University Of Miami Renal stem cells isolated from kidney
RU2702721C2 (ru) 2012-10-24 2019-10-09 инРиджен Популяции клеток почек и их применение
WO2014113704A2 (en) * 2013-01-18 2014-07-24 Escape Therapeutics, Inc. Enhanced differentiation of mesenchymal stem cells
CN104977414B (zh) * 2014-04-09 2016-09-28 上海交通大学医学院 鉴定骨髓中是否存在保护白血病干细胞微环境的试剂盒及其应用
CN106715683A (zh) * 2014-08-21 2017-05-24 味之素株式会社 间充质干细胞用培养基
TWI689589B (zh) * 2016-08-31 2020-04-01 宣捷細胞生物製藥股份有限公司 區別間質幹細胞的方法及測定間質幹細胞的純度的方法
CN106265745A (zh) * 2016-09-30 2017-01-04 广州赛莱拉干细胞科技股份有限公司 一种干细胞制剂及其在制备治疗慢性肾炎的药物中的应用
JP7072777B2 (ja) * 2018-07-03 2022-05-23 株式会社生命科学インスティテュート 慢性腎障害治療のための多能性幹細胞
EP4146787A4 (en) 2020-05-08 2024-06-26 Gallant Pet, Inc. Uterine-derived regenerative cell compositions and uses thereof
CN117871216B (zh) * 2024-03-12 2024-06-04 中日友好医院(中日友好临床医学研究所) 一种石蜡标本中肾小球裂隙膜的三维可视化方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4085410B2 (ja) * 2003-03-14 2008-05-14 株式会社 バイオリンクインク 腎臓幹細胞/前駆細胞、腎臓幹細胞/前駆細胞の分離方法、及び腎疾患の治療方法
ITFI20060099A1 (it) * 2006-04-28 2007-10-29 Azienda Ospedaliera Careggi Popolazione di cellule staminali renali, sua identificazione ed uso per finalita' terapeutiche
CN101595212B (zh) * 2006-10-12 2014-04-30 伊西康公司 肾源细胞及在组织修复和再生中的使用方法

Also Published As

Publication number Publication date
JP2012507304A (ja) 2012-03-29
US9499796B2 (en) 2016-11-22
CN102292434B (zh) 2014-03-12
WO2010052192A1 (en) 2010-05-14
US20110256111A1 (en) 2011-10-20
JP5795737B2 (ja) 2015-10-14
EP2361303B8 (en) 2016-08-10
CN102292434A (zh) 2011-12-21
EP2361303B1 (en) 2016-04-06
PL2361303T3 (pl) 2016-10-31
EP2361303A1 (en) 2011-08-31
EP2186883A1 (en) 2010-05-19

Similar Documents

Publication Publication Date Title
ES2580172T3 (es) Una célula madre mesenquimal multipotente aislada de glomérulos humanos adultos (HGL-MSC), un método para preparar la misma y usos de la misma en la medicina regenerativa del riñón
HRP20180266T1 (hr) Postupak priprave osnovnog medija za kulturu mezenhimnih matičnih stanica, osnovni medij za kulturu mezenhimnih matičnih stanica, te terapijsko sredstvo za stanice koje se uzgaja i diferencira uz njegovu upotrebu
Jeong et al. Human salivary gland stem cells ameliorate hyposalivation of radiation-damaged rat salivary glands
Cheng et al. Isolation and characterization of multipotent stem cells from human cruciate ligaments
JP2016116523A5 (https=)
JP2012507304A5 (https=)
ES2539905T3 (es) Método para aislar y/o identificar células madre mesenquimales (CMM)
CL2019000540A1 (es) Método para aislar células madre mesenquimales a partir de membrana amniótica de cordón umbilical utilizando un medio de cultivo celular resumen de la invención.
Foudah et al. Human mesenchymal stem cells express neuronal markers after osteogenic and adipogenic differentiation
MX350891B (es) Proceso para la preparacion de (2z,5z)-5-(3-cloro-4-((r)-2,3-dihid roxipropoxi) bencilideno)-2-(propilimino)-3-(o-tolil) tiazolidin-4-ona y el intermediario usado en dicho proceso.
MX2018011334A (es) Composiciones y su uso.
PH12021551112A1 (en) Acidic cleaning compositions for enhanced soil removal
Huang et al. Species variation in the spontaneous calcification of bone marrow-derived mesenchymal stem cells
Shih et al. Isolation and characterization of stem cells from the human parathyroid gland
AR112303A1 (es) Método para el tratamiento de un efecto secundario de la inmunoterapia
AR066392A1 (es) Aditivos para el incremento del rendimiento de separacion de jabon de aceite de resina de licores negros
CN103897848A (zh) 一种不干胶清洁剂
Hashemi et al. In vitro immunomodulatory properties of osteogenic and adipogenic differentiated mesenchymal stem cells isolated from three inbred mouse strains
Samad et al. Mesenchymal stem cell conditioned media (MSC-CM) suppress Wnt-3a and TGF-β1-induced myofibroblastic differentiation
ES2628096T3 (es) Composición cosmética de color estable
문영래 et al. Isolation and phenotypic characterization of multipotent mesenchymal-like stem cells from human subacromial bursa
CN107822938A (zh) 一种卸妆油
LI et al. Research on adipose-derived stem cells differentiation induced by supernatant liquid from cerebral infarction tissue in rats
CN104306245A (zh) 一种医用洗手液
CN102784529A (zh) 含百叶窗保护套滤袋框架